跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CD8-IL21
首页
药物
CD8-IL21
CD8-IL21
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Construction method of gene engineering lactic acid bacteria capable of expressing interleukin-21 (IL-21) and application of gene engineering lactic acid bacteria to tumor immnuotherapy
CN 111575309 A
申请人: NANJING FIRST HOSPITAL
优先权: 2019
CN
NK trophoblast cell as well as preparation method and application thereof
CN 112852744 A
申请人: HENAN HUALONG BIOLOGICAL TECH CO LTD
优先权: 2021
CN
IL21-NKG2D CAR-T cell as well as preparation method and application thereof
CN 117305249 A
申请人: SUZHOU INDUSTRIAL PARK INST OF SERVICES OUTSOURCING SUZHOU SERVICE OUTSOURCING TRAINING CENTER
优先权: 2023
CN
T cell culture medium and application thereof
CN 121896165 A
申请人: CHONGQING PREC BIOTECH CO LTD
优先权: 2024
CN
Recombinant chimpanzee oncolytic adenovirus Adsimian-delta24-IL21 as well as construction method and application thereof
CN 121379989 A
申请人: UNIV ZHEJIANG SCIENCE & TECH
优先权: 2025
CN
药物
反馈